CG Oncology CGON Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$60.2M-45.7% | -$41.31M+5.7% | -$43.81M-5.8% | -$41.43M-20.2% | -$34.45M-8.3% | ||
| $841K-0.9% | $849K+104% | $416K+167% | $156K+550% | $24K— | ||
| $6.47M-9.9% | $7.19M-2.0% | $7.33M+4.6% | $7.01M+36.0% | $5.15M+3.2% | ||
| -$56.94M-57.2% | -$36.22M+6.9% | -$38.89M-39.1% | -$27.96M+4.5% | -$29.28M-41.7% | ||
| $304K+4,243% | $7K-92.8% | $97K+593% | $14K-12.5% | $16K-92.3% | ||
| -$334.85M-343% | -$75.51M— | —— | —— | -$186.77M— | ||
| $393M+297% | $99.07M+82.2% | $54.37M— | $0-100% | $450K-99.8% | ||
| $1.21M+110% | -$12.66M— | —— | -$26.85M+87.5% | -$215.6M-201% | ||
| -$57.25M-58.0% | -$36.22M+7.1% | -$38.99M-39.4% | -$27.97M+4.5% | -$29.29M-40.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does CG Oncology's cash flow data come from?
- Every line is extracted from CG Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.